Abstract
Background: Procalcitonin (PCT) is currently the most studied infection biomarker and its blood levels seem to mirror the severity of illness and outcome. PCT is widely used together with other biomarkers, such as white blood cells (WBC) count and C reactive protein (CRP), in order to guide antibiotic therapy. This study aimed to verify the diagnostic and prognostic power of WBC, CRP and PCT in patients with suspected infection in emergency department (ED).
Methods: A total of 513 patients presenting to the ED with signs/symptoms of local infections or sepsis were enrolled. APACHEII score and in-hospital death were recorded. Patients were subdivided into quartiles by age, and the biomarkers were measured at baseline. Receiver operating characteristics (ROC) curves for evaluating diagnostic and prognostic role of PCT, CRP and WBC were calculated for each variable alone and combined.
Results: When compared each other for PCT, CRP, and WBC there was no significant difference between the four subgroups. A direct correlation between PCT and WBC was found in the II, III, and IV quartiles (the highest correlation, r=0.34, p<0.0003). PCT alone or when combined with WBC showed the best diagnostic and prognostic power at ROC analysis.
Conclusions: Our data demonstrate that WBC, but more CRP and PCT are reliable diagnostic and prognostic biomarkers, when considered in combination and with severity clinical score. PCT confirms its stronger usefulness as a diagnostic marker of sepsis. A multi-diagnostic tools approach is fundamental to perform a correct and rapid diagnosis of infection and sepsis in ED.
References
1. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther 2012;10:701–6.10.1586/eri.12.50Search in Google Scholar
2. Knaus WA, Sun X, Nystrom O, Wagner DP. Evaluation of definitions for sepsis. Chest 1992;101:1656–62.10.1378/chest.101.6.1656Search in Google Scholar
3. Maseda E, Mensa J, Valía JC, Gomez-Herreras JI, Ramasco F, Samso E, et al. Bugs, hosts and ICU environment: countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting. Rev Esp Quimioter 2013;26:312–31.Search in Google Scholar
4. Rohde JM, Odden AJ, Bonham C, Kuhn L, Malani PN, Chen LM, et al. The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med 2013;8:243–7.10.1002/jhm.2012Search in Google Scholar
5. Balk RA, Bone RC. The septic syndrome: definition and clinical implications. Crit Care Clin 1989;5:1–8.10.1016/S0749-0704(18)30447-0Search in Google Scholar
6. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–96.10.1097/01.CCM.0000217961.75225.E9Search in Google Scholar PubMed
7. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89–95.10.1067/mcp.2001.113989Search in Google Scholar PubMed
8. Marshall JC, Reinhart K. Biomarkers of sepsis. Crit Care Med 2009;37:2290–8.10.1097/CCM.0b013e3181a02afcSearch in Google Scholar PubMed
9. Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci 2013;50: 23–36.10.3109/10408363.2013.764490Search in Google Scholar PubMed PubMed Central
10. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010;14:R15.10.1186/cc8872Search in Google Scholar PubMed PubMed Central
11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Intens Care Med 2013;39:165–228.10.1007/s00134-012-2769-8Search in Google Scholar PubMed PubMed Central
12. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011;66(Suppl 2):ii33–40.10.1093/jac/dkq523Search in Google Scholar
13. Derlet RW, Richards JR. Overcrowding in the nation’s emergency departments: complex causes and disturbing effects. Ann Emerg Med 2000;35:63–8.10.1016/S0196-0644(00)70105-3Search in Google Scholar
14. Bloos F, Reinhart K. Rapid diagnosis of sepsis. Virulence 2014;5:219–25.10.4161/viru.27393Search in Google Scholar PubMed PubMed Central
15. Jaimes FA, De La Rosa GD, Valencia ML, Arango CM, Gomez CI, Garcia A, et al. A latent class approach for sepsis diagnosis supports use of procalcitonin in the emergency room for diagnosis of severe sepsis. BMC Anesthesiol 2013;13:23.10.1186/1471-2253-13-23Search in Google Scholar PubMed PubMed Central
16. Park M, Azevedo LC, Maciel AT, Pizzo VR, Noritomi DT, Cruz Neto LM. Evolutive standard base excess and serum lactate level in severe sepsis and septic shock patients resuscitated with early goal-directed therapy: still outcome markers? Clinics 2006;61:47–52.10.1590/S1807-59322006000100009Search in Google Scholar PubMed
17. Angele MK, Frantz MC, Chaudry IH. Gender and sex hormones influence the response to trauma and sepsis – potential therapeutic approaches. Clinics 2006;61:479–88.10.1590/S1807-59322006000500017Search in Google Scholar
18. Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G. Reducing mortality in sepsis: new directions. Crit Care 2002;6(Suppl 3):S1–18.10.1186/cc1860Search in Google Scholar PubMed PubMed Central
19. Crea F, Biasucci LM. Innate immune inflammatory response to danger: when, how, and why does a friend become a foe? Eur Heart J 2012;33:1434–7.10.1093/eurheartj/ehs033Search in Google Scholar PubMed
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–74.10.1097/00003246-199206000-00025Search in Google Scholar
21. Horwitz LI, Green J, Bradley EH. US Emergency department performance on wait time and length of visit. Ann Emerg Med 2010;55:133–41.10.1016/j.annemergmed.2009.07.023Search in Google Scholar PubMed PubMed Central
22. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998;102:199–209.10.1016/S0047-6374(97)00153-XSearch in Google Scholar
23. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004;39:687–99.10.1016/j.exger.2004.01.009Search in Google Scholar PubMed
24. Lee SH, Chan RC, Wu JY, Chen HW, Chang SS, Lee CC. Diagnostic value of procalcitonin for bacterial infection in elderly patients, a systemic review and meta-analysis. Int J Clin Pract 2013;67:1350–7.10.1111/ijcp.12278Search in Google Scholar PubMed
25. Loonen AJ, de Jager CP, Tosserams J, Kusters R, Hilbink M, Wever PC, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One 2014;9:e87315.10.1371/journal.pone.0087315Search in Google Scholar PubMed PubMed Central
26. Arai T, Kumasaka K, Nagata K, Okita T, Oomura T, Hoshiai A, et al. Prediction of blood cultures results by measuring procalcitonin levels and other inflammatory biomarkers. Am J Emerg Med 2014;32:330–3.10.1016/j.ajem.2013.12.035Search in Google Scholar PubMed
27. Innocenti F, Bianchi S, Guerrini E, Vicidomini S, Conti A, Zanobetti M, et al. Prognostic score for early stratification of septic patients admitted to an emergency department-high dependency unit. Eur J Emerg Med 2013 Aug 21. [Epub ahead of print].10.1097/MEJ.0000000000000075Search in Google Scholar PubMed
28. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8:234–42.10.1186/cc2877Search in Google Scholar PubMed PubMed Central
29. Meidani M, Khorvash F, Abolghasemi H, Jamali B. Procalcitonin and quantitative C-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia. South Asian J Cancer 2013;2:216–9.10.4103/2278-330X.119913Search in Google Scholar PubMed PubMed Central
30. Magrini L, Travaglino F, Marino R, Ferri E, De Berardinis B, Cardelli P, et al. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases. Eur Rev Med Pharmacol Sci 2013;17(Suppl 1):133–42.Search in Google Scholar
31. Tang H, Jing J, Bo D, Xu D. Biological variations of leukocyte numerical and morphologic parameters determined by UniCelDxH 800 hematology analyzer. Arch Pathol Lab Med 2012;136:1392–6.10.5858/arpa.2011-0679-OASearch in Google Scholar PubMed
32. Caruso C, Buffa S, Candore G, Colonna-Romano G, Dunn-Walters D, Kipling D, et al. Mechanisms of immunosenescence. Immun Ageing 2009;6:10.10.1186/1742-4933-6-10Search in Google Scholar PubMed PubMed Central
33. Falci C, Gianesin K, Sergi G, Giunco S, De Ronch I, Valpione S. Immune senescence and cancer in elderly patients: results from an exploratory study. Exp Gerontol 2013;48:1436–42.10.1016/j.exger.2013.09.011Search in Google Scholar PubMed
34. Prkno A, Wacker C, Brunhorst FM, Schlattman P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock – a systematic review and meta-analysis. Crit Care 2013;17:R291.10.1186/cc13157Search in Google Scholar PubMed PubMed Central
35. Di Somma S, Magrini L, Travaglino F, Lalle I, Fiotti N, Cervellin G, et al. Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clin Chem Lab Med 2013;51:1167–75.10.1515/cclm-2012-0795Search in Google Scholar PubMed
©2014 by De Gruyter
